Michael Luther

Michael Luther Email and Phone Number

Managing Partner @ Bio-Innovations, LLC
Cambridge, MA, US
Michael Luther's Location
Cambridge, Massachusetts, United States, United States
Michael Luther's Contact Details

Michael Luther work email

Michael Luther personal email

About Michael Luther

C-level executive with extensive experience in successfully building and leading life science operations from start-ups to global companies. Built business plans and raised funding for start-up companies to support innovation and growth. Seeking challenging leadership roles at the executive level to integrate entrepreneurial experience with vast business, scientific, and drug development skills. Executive and C-level experiences include start-ups, global pharmaceutical, and CRO companies. International management and leadership experience (UK, Canada, Japan, India) at global pharmaceutical and CRO companies. Multiple Board of Director roles (public, private, and not-for -profit) and over 70 peer reviewed publications and patents. Specialties: • Drug Discovery & Development (Target ID to Phase ll) (oncology, metabolic disease, and immunology)• Strategic Planning & Corporate Development including business development, M&As, Public-Private Consortia, Board of Director roles in public and private companies as well as academic institutions/foundations• Drug Discovery• Precision Medicine• Drug Repositioning • Business Development• Start-ups & Turnaround Change Management • Global Business, Science, and Management Experience

Michael Luther's Current Company Details
Bio-Innovations, LLC

Bio-Innovations, Llc

View
Managing Partner
Cambridge, MA, US
Michael Luther Work Experience Details
  • Bio-Innovations, Llc
    Managing Partner
    Bio-Innovations, Llc
    Cambridge, Ma, Us
  • Strm.Bio
    Chief Executive Officer And Board Of Directors
    Strm.Bio Jun 2024 - Present
    Boston, Ma, Us
    STRM.BIO is a seed stage gene therapy company that has developed a unique gene delivery platform (megakaryocyte extracellular vesicles (MVs)) to deliver complex payloads (DNA, RNA, and proteins). These MVs home to bone marrow stem cells by-passing the liver (unlike AAV or LNP) which provides the ability for direct targeting and due to their allogenic properties ability to multi-dose. Current pipeline is focused on Fanconi Anemia and Sickle Cell Disease.
  • Massbio
    Director Board Of Directors
    Massbio 2023 - Present
    Cambridge, Massachusetts, Us
  • Bio-Innovations, Llc
    Managing Partner
    Bio-Innovations, Llc Jan 2016 - Present
    Life science management consulting firm focused on helping start-up companies from company formation, creation and implementation from early-stage product discovery through development.
  • Bantam Pharmaceutical
    Member Board Of Directors
    Bantam Pharmaceutical 2016 - Present
    Durham, North Carolina, Us
    Board of Director for this start-up biotech I founded focused on the development of cancer therapeutics that modulate the integrated stress response via a novel mitochondrial driven mechanism. Using a precision-medicine based approach, we are progressing pipeline towards clinical proof of concept studies in hematologic and solid cancers.
  • Bantam Pharmaceutical
    Founding Ceo And President
    Bantam Pharmaceutical Oct 2015 - Mar 2021
    Durham, North Carolina, Us
    Founding CEO of this start up focused on the development of cancer therapeutics that modulate the integrated stress response via a novel mitochondrial driven mechanism. Using a precision-medicine based approach, we are progressing pipeline towards clinical proof of concept studies in hematologic and solid cancers.
  • Astellas Pharma
    Global Head Search & Evaluation Business Development
    Astellas Pharma 2021 - 2023
    Developed strategies and approaches including integrating and leading global efforts with teams in North America, Europe, and Asia to identify and assess early and late stage business development investments and deals including spin-outs to impact current and future drug development pipeline efforts for Astellas. Team initiated and led >9 deals including spin-out NewCos in line with Astellas strategy.
  • Precipio, Inc
    Member Board Of Directors
    Precipio, Inc 2013 - 2018
    New Haven, Ct, Us
    Board of director for publicly listed (NASDAQ) clinical diagnostics company focused on delivering precision medicine approaches in oncology and virology.
  • Albany Molecular Research, Inc. (Amri)
    Senior Vice President Discovery & Development
    Albany Molecular Research, Inc. (Amri) 2012 - 2015
    Albany, Ny, Us
    Served as General Manager for this global CRO, responsible for world-wide drug discovery and development division with $98+ million P/L. Role included business and scientific operations as well as strategic, operational, and business development activities. Division provided early and late stage integrated Drug Discovery, and Development services, and expertise for customers ranging from academia to pharma. Global operational responsibilities included sites in US, India, and Singapore.
  • David H. Murdock Research Institute And North Carolina Research Campus
    President And Board Of Director
    David H. Murdock Research Institute And North Carolina Research Campus 2009 - 2012
    As founding President, and member of the Board of Directors for the led and directed all activities of this 501(c)3 start-up research-focused organization. Institute and campus activities focused on the translation and development of technology and products for life science companies ranging from diagnostics and therapeutics to nutrition and agriculture. Partners included academia, venture groups, start-ups, and established global companies.
  • Merck
    Vice President Drug Discovery And Montreal (Merck-Frosst) Site Head
    Merck 2006 - 2009
    Rahway, New Jersey, Us
    Directed work of this global pharma drug discovery and development site of 250+ employees in ($57 million annual budget) focused on delivery of Phase II clinical therapeutics in inflammation and metabolic disorders until site was closed post Merck-Schering merger. Executive on both global Merck Research Labs, and the Merck Frosst Commercial Operation Committees.
  • Gsk
    Drug Hunter
    Gsk Oct 1991 - Nov 2006
    Brentford, Middlesex, Gb
    In various roles over 15+ years, built and implemented successful global drug discovery and development divisions to challenge current paradigms for drug discovery and translational medicine. Established pharma industry’s first precision medicine, and drug repurposing platforms and through systems-based approaches led and contributed to the discovery and development of 5 marketed products.
  • Gsk
    Vice President Drug Discovery
    Gsk Feb 2001 - Oct 2006
    Brentford, Middlesex, Gb
    Built and implemented successful global division (>250 employees in US, UK, & Japan; $40 million annual budget) established to challenge paradigms for drug discovery and translational medicine. Established pharma industry’s first drug repurposing platform to create new pipeline and commercial opportunities
  • Glaxo-Wellcome
    Director And Head, Predictive Medicine, Pharmacogenetics, And Applied Diagnostics
    Glaxo-Wellcome 1999 - 2001
    As Director, and founding member, built pharma industry first precision medicine business unit from inception including obtaining funding from CEO. Established operations ranging from R&D to strategic partnerships with external diagnostics companies. This new venture in precision medicine accelerated and increased the success of GSK’s pipeline via differentiation and expansion of market opportunities for both development and marketed assets.
  • Glaxo Pharmaceuticals
    Department Head Molecular Sciences
    Glaxo Pharmaceuticals 1991 - 1999
    Built successful drug discovery department that made major contributions to every early product development for Glaxo’s US R&D organization (oncology, metabolic disease, inflammation, and virology). Led target identification to screen, and structure-based drug design efforts for all US based drug discovery programs.
  • Procept, Inc.
    Principal Scientist- Biochemistry And Immunotherapeutics
    Procept, Inc. 1988 - 1991
    As Principal Scientist, and fourth employee for this Harvard spin-out, established biochemistry, biophysical, and bioprocess operations for bio-pharmaceutical focused start-up. Directed R&D programs focused on immunotherapeutic biopharmaceuticals (CD2, CD4, and scTCR) for treatment of HIV and auto-immune diseases. Assets progressed to Phase IIa.
  • Salk Institute For Biological Studies
    Muscular Dystrophy Association Fellow
    Salk Institute For Biological Studies 1985 - 1988
    La Jolla, Ca, Us
    Muscular Dystrophy Fellow working on acetylcholine receptor and Myasthenia Gravis

Michael Luther Skills

Leadership Cancer Research Research And Development Strategic Partnerships Translational Medicine New Venture Creation Cro Systems Biology Executive Management Product Differentiation Bio Pharma Non Profit Management Proteomics Genomics Infectious Diseases Start Ups Biotechnology Business Development Negotiation Immunology Fundraising Strategy Management Consulting Drug Discovery Business Planning Lifesciences Cro Management Entrepreneurship Oncology New Business Development Drug Development Bioinformatics Clinical Development Change Management Contract Negotiation Pharmacology Business Strategy Management Pharmaceutical Industry Corporate Development Technology Transfer Venture Capital Mergers And Acquisitions Personalized Medicine Biomarkers R&d Board Of Directors Protein Chemistry Venture Financing Biopharmaceuticals

Michael Luther Education Details

  • Saint Louis University School Of Medicine
    Saint Louis University School Of Medicine
    Biophysics
  • Duke University - The Fuqua School Of Business
    Duke University - The Fuqua School Of Business
    Healthcare
  • North Carolina State University
    North Carolina State University
    Biology And Chemistry
  • Harvard Law School
    Harvard Law School
    Program On Negotiation
  • Harvard T.H. Chan School Of Public Health
    Harvard T.H. Chan School Of Public Health
    Advanced Training In Biomedical Research Management
  • The Center For Creative Leadership
    The Center For Creative Leadership
    Leading For Organizational Impact
  • Duke University - The Fuqua School Of Business
    Duke University - The Fuqua School Of Business
    Mba

Frequently Asked Questions about Michael Luther

What company does Michael Luther work for?

Michael Luther works for Bio-Innovations, Llc

What is Michael Luther's role at the current company?

Michael Luther's current role is Managing Partner.

What is Michael Luther's email address?

Michael Luther's email address is mi****@****las.com

What is Michael Luther's direct phone number?

Michael Luther's direct phone number is +170425*****

What schools did Michael Luther attend?

Michael Luther attended Saint Louis University School Of Medicine, Duke University - The Fuqua School Of Business, North Carolina State University, Harvard Law School, Harvard T.h. Chan School Of Public Health, The Center For Creative Leadership, Duke University - The Fuqua School Of Business.

What skills is Michael Luther known for?

Michael Luther has skills like Leadership, Cancer Research, Research And Development, Strategic Partnerships, Translational Medicine, New Venture Creation, Cro, Systems Biology, Executive Management, Product Differentiation, Bio Pharma, Non Profit Management.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.